COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Agenda Clinical Hematology & Oncology 2022

Friday, February 11, 2022

11 a.m.

Registration Opens

 

12:30 p.m.

Break & View Exhibits

 

Non-Malignant Hematology

 

12:50 p.m.

Welcome & Educational Overview

Michael Kosty, MD

                                       

1 p.m.

Hematologic Complications of COVID-19 and COVID-19 Vaccines         

 

1:30 p.m.

The Five things Every Practicing Oncologist Should Know About Clinical Non-Malignant Hematology

                                       

2 p.m.

Unusual Thrombosis

                                       

2:30 p.m.

Panel Discussion/Q&A

                                       

3 p.m.

Break & View Exhibits

 

3:15 p.m.

Management of Bleeding Disorders in Pregnancy

                                       

3:45 p.m.

Unexplained Arterial Thromboembolism

                                       

4:15 p.m.

A Practical Approach to ITP Management

                                       

4:45 p.m.

Panel Discussion/Q&A

                                       

5:15 p.m.

Adjourn

Saturday, February 12, 2022

6:45 a.m.

Breakfast Symposium

Non-CME Event Hosted by Pfizer, Inc.

 

7 a.m.

Breakfast & View Exhibits

 

Malignant Hematology

 

7:55 a.m.

Welcome & Announcements

                                       

8 a.m.

Elderly AML Treatment

                                       

8:30 a.m.

Amyloidosis Update: The Role of Daratumumab

                                       

9 a.m.

Treatment of Refractory Follicular Lymphoma

                                       

9:30 a.m.

Panel Discussion/Q&A

                                       

10 a.m.

Break & View Exhibits

 

10:30 a.m.

Different Types of Peripheral T-cell NHL and Their Treatment

                                       

11 a.m.

Familial Predisposition to AML

                                       

11:30 a.m.

The Role of Anti-CD19 Antibodies in the Treatment of Relapsed/Refractory B-cell Lymphoma

                                       

Noon

Panel Discussion/Q&A

                                       

12:30 p.m.

Lunch

 

12:30-1:30 p.m.

Lunch Symposium

Non-CME Event Hosted by Rigel Pharmaceuticals

 

Malignant Hematology

 

1:30 p.m.

What’s New in CAR-T Therapy?

                                       

2 p.m.

Treatment of Advanced Hodgkin Disease

                                       

2:30 p.m.

Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care

                   

3 p.m.

Panel Discussion/Q&A

                                       

3:30 p.m.

Break & View Exhibits

 

Concurrent Breakout Sessions: Clinical Cases

 

4 p.m.

Breakout #1: Clinical Cases in Thrombosis

                                       

Breakout #2: Clinical Cases in Bleeding

                                       

Breakout #3: Clinical Cases in Leukemia

                                       

Breakout #4: Clinical Cases in Myeloma

                                       

5 p.m.

Adjourn

Sunday, February 13, 2022

7 a.m.

Breakfast & View Exhibits

 

Melanoma, Genitourinary, GI

 

7:50 a.m.

Welcome & Announcements

                                       

8 a.m.

Adjuvant Therapy of Malignant Melanoma

                                       

8:30 a.m.

Updates in Gynecologic Oncology

                                       

9 a.m.

The Emerging Role for Cell Therapy in Upper GI Cancers

                                       

9:30 a.m.

Panel Discussion/Q&A

                   

10 a.m.

Break & View Exhibits

 

10:30 a.m.

Updates in Hepatocellular Cancer

                   

11 a.m.

Management of Metastatic Urothelial Carcinoma – Frontline Treatment Selection

                                       

11:30 a.m.

Sequencing Therapies in Metastatic Prostate Cancer

                                       

Noon

Panel Discussion/Q&A

                                       

12:30 p.m.

Lunch

 

12:30-1:30 p.m.

Lunch Symposium

Non-CME Event Hosted by Seagen

 

1:30 p.m.

New Drugs for the Management of Breast Cancer

                                       

2 p.m.

Neoadjuvant/Adjuvant Therapy of Triple Negative Breast Cancer

                                       

2:30 p.m.

New Approaches to the Management of Her-2 Positive Breast Cancers

                                       

3 p.m.

Panel Discussion/Q&A

                                       

3:30 p.m.

Break & View Exhibits

 

3:45 p.m.

Novel Approaches to EGFR mutated NSCLC

                                       

4:15 p.m.

Practical Approach to Selection of Frontline Therapy in NSCLC Without Driver Mutation

                   

4:45 p.m.

Management of Immune-Related Toxicities

                                       

5:15 p.m.

Panel Discussion/Q&A

                                       

5:45 p.m.

Final Adjournment

 

Please note:

  • All times are listed in Pacific Time (PT).
  • Topics, times, and speakers are subject to change.